RhAPPcast

RhAPPcast

Por: Rheumatology Advanced Practice Providers (RhAPP)
This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). 
 
Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases. 
130 episodios disponibles

Latest episodes of the podcast RhAPPcast

Mostrando página 2 de 7

Medication Review: Leflunomide Medication Review 14/08/2025
RhAPPcast: Spotting the Signs: Recognizing and Diagnosing Giant Cell Arteritis 12/08/2025
RhAPPcast: Foundations of PMR: Diagnosis, First-Line Therapy, and Tapering Strategies 05/08/2025
Journal Club Review: Sarilumab for Relapse of Polymyalgia Rheumatica During Glucocorticoid Taper 22/07/2025
FAQ: Steroid-Sparing Agent Consideration in PMR Management & What Options Are Available? 15/07/2025
FAQ: What Are the Most Recent Treatment Guidelines for PMR, and What Are the Key Clinical Takeaways? 08/07/2025
Medication Review: What is the Mechanism of Action of Methotrexate? 01/07/2025
Journal Club Review: A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis 26/06/2025
RhAPPcast: Understanding the TYK2/STAT Signaling Pathway in PsA: Clinical Implications and Beyond 19/06/2025
Medication Review: Hydroxychloroquine Medication Review 17/06/2025
FAQ: How Does the Selectivity of TYK2 and JAK Enzyme Inhibition Influence Their Safety Profiles 12/06/2025
FAQ: According to the New 2024 ACR Guidelines for Lupus Nephritis, How Do You Monitor LN? 09/06/2025
FAQ: Can You Recapture Response to IL-17i Therapy After Interruption or Discontinuation in Therapy? 04/06/2025
FAQ: Steroid Tapering in Lupus Nephritis: Insights from the 2024 ACR Guidelines 29/05/2025
Medication Review: What Is the Safety Profile of Deucravacitinib in PsO and PsA? 26/05/2025
Journal Club Review: Voclosporin in Lupus Nephritis: New Insights on Efficacy & Safety from Clinical Trials 23/05/2025
Medication Review: What is the Mechanism of Action of Deucravacitinib? 19/05/2025
RhAPPcast: Practical Application: Integrating the New ACR LN Guidelines 16/05/2025
Medication Review: What is the Real World Evidence of Guslekumab in PsA 14/05/2025
FAQ: TYK2/STAT Pathway & Why TYK2 Therapy Works for Psoriasis and Psoriatic Arthritis 09/05/2025
« Primera ‹ Anterior 1 2 3 4 ... 7 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA